Dan A. Dixon, PhD
Co-Program Leader, Cancer Prevention, The University of Kansas Cancer Center
Associate Professor, Department of Cancer Biology, The University of Kansas School of Medicine
The focus of Dr. Dixon’s research is on understanding the molecular basis of altered gene expression observed in colon cancer and chronic inflammatory diseases. His laboratory has made seminal discoveries establishing the role of post-transcriptional gene regulation in colorectal cancer and has identified new factors in this pathway as cancer therapeutic targets. His research is currently funded by the National Cancer Institute and he was named an American Cancer Society Research Scholar in 2006, with accompanying funds to investigate the role of COX-2 in colorectal cancer development. Dr. Dixon’s work has been published in prestigious journals such as Cell, Journal of Clinical Investigation, and Gastroenterology. He serves on the editorial board for Cancer Research and has been a frequent grant reviewer for various national and international foundations, including the National Institutes of Health, Department of Defense, Susan G. Komen Breast Cancer Foundation, and American Heart Association. Dr. Dixon also serves as Scientific Training Advisor for the Fight Colorectal Cancer National Advocacy Foundation.
Dr. Dixon earned his Ph.D. in molecular biology and biochemistry at Northwestern University Medical Center in 1994, going on to complete a postdoctoral fellowship in human molecular biology and genetics at the University of Utah. From 2001 to 2004, he was a research assistant professor in the division of surgical oncology at Vanderbilt University Medical Center. Before moving to Kansas, he was an associate professor of biological sciences and associate director of the Center for Colon Cancer Research at the University of South Carolina.